Current Diabetes News
advertisement
Current Research News - June 12, 2019
- An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes (see also: from TrialNet)
- Autoantibodies Directed to a Novel IA-2 Variant Protein Enhance Prediction of Type 1 Diabetes (HTML)
- Hemoglobin A1c Trajectory in Pediatric Patients with Newly Diagnosed Type 1 Diabetes (HTML)
- A New Animal Model of Insulin-Glucose Dynamics in the Intraperitoneal Space Enhances Closed-Loop Control Performance
- Incidence of severe hypoglycemia and possible associated factors in pediatric patients with type 1 diabetes mellitus in the real-life, post-DCCT setting: a systematic review (HTML)
- 3D printed polyamide macroencapsulation devices combined with alginate hydrogels for insulin-producing cell-based therapies (HTML)
- Early nerve fibre regeneration in individuals with type 1 diabetes after simultaneous pancreas and kidney transplantation (HTML | PDF)
- Hybrid Insulin Peptides are Autoantigens in Type 1 Diabetes (HTML)
- Efficacy and safety of ipragliflozin add-on therapy to insulin in Japanese patients with type 1 diabetes mellitus: A randomized, double-blind, phase 3 trial (HTML)
- Maternal microchimerism in cord blood and risk of childhood-onset type 1 diabetes (HTML)
- Fatty Liver Among Adolescent Offspring of Women With Type 1 Diabetes (the EPICOM Study) (HTML)
- Risk Factors for Atrial Fibrillation in People With Type 1 Diabetes: An Observational Cohort Study of 36,258 Patients From the Swedish National Diabetes Registry (HTML)
- The Influence of Type 2 Diabetes-Associated Factors on Type 1 Diabetes (HTML)
- Abnormal Cortical and Trabecular Bone in Youth With Type 1 Diabetes and Celiac Disease (HTML)
- Glucose-Responsive Composite Microneedle Patch for Hypoglycemia-Triggered Delivery of Native Glucagon (HTML)
- Risk factors for diabetic kidney disease in adults with longstanding type 1 diabetes: results from the Canadian Study of Longevity in Diabetes (HTML)
Current Daily Care News - June 12, 2019
- Early Initiation of Diabetes Devices Relates to Improved Glycemic Control in Children with Recent-Onset Type 1 Diabetes Mellitus (HTML)
- Consistent Use of Diabetes Technology Across Multiple Environments Benefits Youth with Diabetes
- Use of Artificial Intelligence to Improve Diabetes Outcomes in Patients Using Multiple Daily Injections Therapy (HTML)
- Assessing the efficacy, safety and utility of 6-month day-and-night automated closed-loop insulin delivery under free-living conditions compared with insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, multicentre, multinational, single-period, randomised, parallel group study protocol (HTML)
- Efficacy and Safety of Real Life Usage of MiniMed 670G Automode in Children with Type 1 Diabetes Less than 7 Years Old (HTML)
- Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range (PDF)
- Expert Panel Defines CGM Time-in-Range Targets
- The Carbohydrate Counting in Adolescents With Type 1 Diabetes (CCAT) Study
- Pre-Exercise Blood Glucose Levels Determine the Amount of Orally Administered Carbohydrates during Physical Exercise in Individuals with Type 1 Diabetes-A Randomized Cross-Over Trial (HTML)
- Physical workload and glycemia changes during football matches in adolescents with type 1 diabetes can be comparable (HTML)
- Resources to Guide Exercise Specialists Managing Adults with Diabetes (HTML)
- Insulin Access and Affordability Working Group: Conclusions and Recommendations
- High Blood Pressure and Elevated Glucose Levels Present Comparable Risk for Young Adults with Type 1 Diabetes to Develop Heart Disease
- Long-Term Effectiveness of Continuous Subcutaneous Insulin Infusion in the Prevention of Hypoglycemia in Adults with Type 1 Diabetes (HTML)
- Marked improvement in HbA1c following commencement of flash glucose monitoring in people with type 1 diabetes (HTML | PDF)
- Exploring Patient Preferences for Adjunct-to-Insulin Therapy in Type 1 Diabetes (HTML)
- Psychological support for adolescents with type 1 diabetes provided by adolescents with type 1 diabetes: The chat line experience (HTML)
- Descriptions of diabetes burnout from individuals with Type 1 diabetes: an analysis of YouTube videos (HTML)
- Enablers and barriers to effective diabetes self-management: A multi-national investigation (HTML)
- Effects of Motivational Interviewing on Adherence to Treatment Regimens Among Patients With Type 1 Diabetes: A Systematic Review
- Family Diabetes Camp: Fostering Resiliency Among Campers and Parents
- “Diabetes Just Tends to Take Over Everything”: Experiences of Support and Barriers to Diabetes Management for Pregnancy in Women With Type 1 Diabetes
- Modelling potential cost savings from use of real-time continuous glucose monitoring in pregnant women with Type 1 diabetes (HTML)
- Utilizing eHealth and Telemedicine Technologies to Enhance Access and Quality of Consultations: It’s Not What You Say, It’s the Way You Say It (HTML)
- Duration of Insulin Supply in Type 1 Diabetes: Are 90 Days Better or Worse Than 30 Days?
Current Legislative & Policy News - June 5, 2019
Current Diabetes News in the Popular Press - June 12, 2019
- New law allows emergency refills of crucial medication
- ‘Make It Free’: Inside the Rising Insulin Price Crisis That Diabetics Say Is Putting Them on the Edge of Life or Death
- Mother says son removed from Legoland ride because of insulin pump
- 13-year-old Mainer’s medical invention gains national recognition
- Experimental drug delays type 1 diabetes onset in mid-stage trial
Current Celiac News - June 12, 2019
Current Press Releases - June 12, 2019
- Tandem Diabetes Care Reports Positive Results From Two Studies of the t:slim X2 Insulin Pump With Control-IQ Technology
- Insulet’s Omnipod® Horizon™ Hybrid Closed-Loop System Improves Glycemic Control in Patients as Young as Two Years Old with Type 1 Diabetes
- Dexcom and Companion Medical Announce Collaboration to Integrate Dexcom CGM Data and InPen™ Insulin Data
- Beta Bionics and Zealand Pharma announce superior glycemic control in Phase 2 home-use clinical trial testing the iLet™ bionic pancreas using dasiglucagion
- Xeris Pharmaceuticals Receives Notification of PDUFA Date Extension for Gvoke™
- Senseonics Announces FDA Approval for a Non-Adjunctive Indication (Dosing Claim) for the Eversense® 90-day CGM System
- Medtronic and Tidepool Work Together on Interoperable Automated Insulin Pump System for Diabetes Management
- Medtronic Initiates Pivotal Trial for Bluetooth Enabled MiniMed(TM) 780G Advanced Hybrid Closed Loop System Designed to Automate Correction Bolusing
advertisement